Atrial Natriuretic Peptide (ANP), Rat: Precision Peptide for Cardiovascular and Renal Research

Executive Summary: Atrial Natriuretic Peptide (ANP), rat, is a 28-amino acid peptide hormone with a defined sequence (H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-OH) and a molecular weight of 1225.38 Da, produced by atrial myocytes in response to atrial stretch and neurohumoral stimuli (APExBIO product page). ANP is a potent vasodilator and natriuretic agent that regulates blood pressure and volume by promoting sodium and water excretion in the kidneys (Vasonatrin-Peptide.com). APExBIO’s A1009 product is validated for ≥95.92% purity by HPLC and mass spectrometry, ensuring reproducibility in cardiovascular and renal physiology models. ANP is soluble at ≥122.5 mg/mL in DMSO and ≥43.5 mg/mL in water, but insoluble in ethanol, and should be stored at -20°C for stability. Its research applications span mechanistic studies of natriuresis, blood pressure regulation, and adipose tissue metabolism in rat models (Zhang et al. 2022).

Biological Rationale

Atrial Natriuretic Peptide (ANP) is synthesized, stored, and secreted by atrial myocytes in response to atrial distension, angiotensin II, endothelin, and sympathetic nervous system activation (APExBIO). ANP acts systemically to reduce circulating blood volume and pressure by promoting renal sodium and water excretion (natriuresis and diuresis). This effect is mediated through the activation of natriuretic peptide receptors, leading to increased cyclic guanosine monophosphate (cGMP) in target tissues. ANP also influences adipose tissue metabolism by modulating lipolysis and adiponectin secretion, intersecting with neuroimmune and metabolic signaling pathways (Zhang et al. 2022). The peptide’s physiological roles make it a critical tool for research in blood pressure homeostasis, cardiovascular disease, and kidney function.

Mechanism of Action of Atrial Natriuretic Peptide (ANP), rat

ANP binds to natriuretic peptide receptor A (NPR-A) on renal and vascular tissues, stimulating guanylate cyclase activity and elevating intracellular cGMP. This cascade produces vasodilation, increases glomerular filtration rate (GFR), and inhibits sodium reabsorption in the distal nephron. The molecular sequence of the rat peptide (H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-OH) confers specificity for NPR-A activation in rodent models (Vasonatrin-Peptide.com). ANP also suppresses renin and aldosterone secretion, reducing the actions of the renin–angiotensin–aldosterone system (RAAS). In adipose tissue, ANP promotes lipolysis and increases adiponectin production, indirectly affecting neuroinflammatory pathways and metabolic regulation (Zhang et al. 2022).

Evidence & Benchmarks

• ANP induces dose-dependent natriuresis (urinary sodium excretion) in rat models, with significant increases observed at concentrations ≥1 μg/kg administered intravenously (Smith et al. 2018, DOI).
• ANP reduces mean arterial pressure by 10–25 mmHg within 30 minutes of intravenous administration in hypertensive rats, under normothermic conditions (APExBIO, product page).
• Peptide solubility benchmarks: ≥122.5 mg/mL in DMSO and ≥43.5 mg/mL in water at room temperature (APExBIO technical data, product page).
• Purity confirmed at 95.92% by HPLC and mass spectrometry, ensuring experimental reproducibility (APExBIO, product page).
• In models of neuroinflammation, ANP’s modulation of adiponectin signaling has been linked to reduced oxidative stress via TLR4/MyD88/NF-κB pathway inhibition (Zhang et al. 2022, DOI).

This article extends the protocol-focused discussion in Atrial Natriuretic Peptide in Rat: Applied Workflows by providing detailed mechanistic and benchmark data, and updates the mechanistic scope compared to Atrial Natriuretic Peptide (ANP), rat: Atomic Mechanisms by integrating recent findings on neuroimmune interactions.

Applications, Limits & Misconceptions

ANP, rat, is used widely in:

• Cardiovascular research: Blood pressure regulation, heart failure modeling, and vasodilatory response studies.
• Renal physiology: Investigations of natriuresis, diuresis, and glomerular filtration mechanisms.
• Adipose tissue metabolism: Exploring links between natriuretic peptides and adiponectin, as well as neuroimmune modulation (Zhang et al. 2022).

However, ANP is not a therapeutic agent; it is strictly for experimental use in preclinical models. Its effects are species- and context-dependent. For example, direct translation of rat ANP data to human physiology requires caution due to sequence and receptor differences. The peptide is also unstable in solution over extended periods and should be freshly prepared before use.

Common Pitfalls or Misconceptions

• ANP is not effective when stored in solution for >24 hours at room temperature; degradation affects activity.
• It is insoluble in ethanol; attempts to dissolve in ethanol will fail and may denature the peptide.
• ANP should not be used to infer direct clinical efficacy; it is a research-only reagent.
• Species differences in receptor affinity and sequence mean that rat ANP data may not extrapolate directly to human systems.
• Chronic or repeated dosing protocols require validated stability and degradation profiles.

Workflow Integration & Parameters

APExBIO’s A1009 ANP product is supplied as a solid, with a recommended storage temperature of -20°C. For experimental use, dissolve in DMSO (≥122.5 mg/mL) or water (≥43.5 mg/mL) immediately before application. Avoid long-term storage of solutions. For in vivo rat studies, typical dosing is 1–10 μg/kg intravenously; for ex vivo tissue assays, concentrations are titrated based on the endpoint (e.g., 10–100 nM for cGMP or contractility studies). End-users should confirm peptide identity and purity via HPLC/mass spectrometry if regulatory compliance is required. APExBIO ensures a purity of at least 95.92% for every lot. For protocol enhancements, troubleshooting strategies, and advanced use-cases, see Atrial Natriuretic Peptide: Precision Tool for Cardiovascular Research, which this article expands by providing updated mechanistic and solubility benchmarks.

Conclusion & Outlook

Atrial Natriuretic Peptide (ANP), rat, is a validated tool for dissecting blood pressure regulation, natriuresis, and metabolic signaling in preclinical models. The APExBIO A1009 product enables high-fidelity, quantitative experimentation due to its defined sequence and high purity. As new data emerge on the cross-talk between natriuretic peptides, adipokines, and neuroimmune pathways, ANP will remain indispensable for both basic and translational research in cardiovascular and renal physiology. For product specifications and ordering, visit Atrial Natriuretic Peptide (ANP), rat.